Keytruda 100 MG/4 ML vial 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEH0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $152,114
Award facts
- Contract value 100% obligated
- $152,113.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $152,113.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. The delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support Department of Defense medical supply requirements globally.
DMS Pharmaceutical Group's award under the PPV-G GEN V initiative reflects its established capability as a critical pharmaceutical supplier for military healthcare operations. The company's IDC, designated SPE2DR and valued at up to $499,999,999 with a completion date of December 31, 2036, authorizes the DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. As one of multiple regional prime vendor contractors within this broader program, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders, positioning it as a key supplier for the Department of Defense's specialized pharmaceutical and medical consumables requirements.
Quick answers
Who was awarded contract SPE2DR26FMEH0?
SPE2DR26FMEH0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMEH0 worth?
The government has obligated $152,114 on SPE2DR26FMEH0.
Is contract SPE2DR26FMEH0 an order under another contract?
Yes. SPE2DR26FMEH0 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEH0 competed?
The extent of competition for SPE2DR26FMEH0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award